UBE2C and neoplasm: In the present study, we demonstrated that by targeting UbcH10 and KIAA0101, SAC function could be effectively preserved, and tumor growth could be significantly inhibited, suggesting that UbcH10 and KIAA0101 are potential therapeutic targets in NSCLC that modulate SAC function.